PA-25-080
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
Summary
NIH Support for Conferences and Scientific Meetings (R13)
Research Focus & Contribution
The R13 Research Conference Grant supports high-quality scientific conferences, symposia, seminars, and workshops—whether conducted face-to-face or virtually—that advance NIH's mission and public health. The program funds forums where researchers and stakeholders exchange technical information, explore defined scientific problems, and clarify knowledge areas across the full spectrum of biomedical and behavioral research. Participating institutes span oncology, neurology, infectious disease, genomics, aging, child health, environmental health, nursing research, drug abuse, dental research, and complementary medicine, among others. Conferences may result in published reports and are expected to foster safe, inclusive, and harassment-free environments that support full participation from the research community.
At-a-Glance
- Who can apply: Organizations eligible to receive NIH grants (not specified further in excerpt; see full FOA for institutional eligibility details).
- Funding & project length: Not stated in excerpt.
- Award mechanism: R13 Research Conference Grant.
- Key dates: Application due dates December 12, 2024; April 12, 2025; August 12, 2025 (and recurring quarterly). Earliest start dates range from July 2025 onward depending on submission cycle.
- Best fit for: Organizers of scientific meetings in biomedical, behavioral, and health research disciplines seeking to convene researchers, clinicians, and stakeholders for knowledge exchange and community building.
Key Facts
Deadline
Tue, September 7, 2027
Posted
Tue, October 1, 2024
Keywords
Research Areas
Gotchas (4)
NIMH withdrew from participation in PA-25-080 as of June 9, 2025 (NOT-MH-25-210), but had previously announced participation (NOT-MH-25-035 on October 10, 2024). Applicants targeting NIMH funding unde
95%
Source Text
“June 9, 2025 - Notice of NIMH Withdrawal from Participation in PA-25-080, 'NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)'. See Notice NOT-MH-25-210.”
Clinical trials are explicitly not allowed under this R13 mechanism, but the FOA does not clearly define what constitutes a 'clinical trial' in the conference context, creating ambiguity about whether
75%
Source Text
“NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)”
The FOA was updated on March 31, 2025 with instruction to 'Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission,' but the specific chan
80%
Source Text
“March 31, 2025 - This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.”
A notice dated February 10, 2026 states 'NIH No Longer Requires Advanced Permission for Conference Grant Applications' (NOT-OD-26-040), but the provided FOA text does not mention any requirement for a
70%
Source Text
“February 10, 2026 - NIH No Longer Requires Advanced Permission for Conference Grant Applications. See Notice NOT-OD-26-040.”